Table 1.
Correlation analysis between n340790 expression and the clinicopathological characteristics of patients with thyroid cancer
| Characteristics | No. of patients | Mean ± SD | P value |
|---|---|---|---|
| Total no. of patients | 85 | ||
| Age (year) | |||
| < 60 | 41 (48.2%) | 10.31 ± 1.32 | 0.414 |
| ≤ 60 | 44 (51.8%) | 10.09 ± 1.15 | |
| Gender | |||
| Male | 35 (41.2%) | 10.47 ± 1.62 | 0.077 |
| Female | 50 (58.8%) | 9.93 ± 1.16 | |
| Invasion | |||
| T0-T2 | 54 (63.5%) | 10.54 ± 1.26 | 0.032* |
| T3-T4 | 31 (36.5%) | 9.74 ± 2.13 | |
| Lymphatic metastasis | |||
| N0 | 59 (69.4%) | 11.14 ± 1.46 | < 0.0001*** |
| N1-N3 | 26 (30.6%) | 8.97 ± 2.02 | |
| Distal metastasis | |||
| M0 | 67 (78.8%) | 11.07 ± 2.47 | 0.014* |
| M1 | 18 (21.2%) | 9.48 ± 2.17 | |
| TNM stage | |||
| 0 & I | 61 (71.8%) | 10.94 ± 2.15 | < 0.0001*** |
| II & III & IV | 24 (28.2%) | 8.59 ± 1.57 |
*
Indicated statistical significance (P < 0.05);
***
Indicated statistical significance (P < 0.001).